Aptamer for typing different subtypes of non-small cell lung cancer and method for screening the same

A non-small cell lung cancer and nucleic acid aptamer technology, which is applied in library screening, biochemical equipment and methods, and microbial measurement/testing, can solve the problems of insufficient specificity and sensitivity, and achieve accurate diagnosis

Active Publication Date: 2009-09-23
INST OF CHEM CHINESE ACAD OF SCI
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although tumor markers such as neuron-specific enolase, cytokeratin fragment 21-1, carcinoembryonic antigen, and carbohydrate antigen are currently used in the detection and postoper

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aptamer for typing different subtypes of non-small cell lung cancer and method for screening the same
  • Aptamer for typing different subtypes of non-small cell lung cancer and method for screening the same
  • Aptamer for typing different subtypes of non-small cell lung cancer and method for screening the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1. Screening of nucleic acid aptamers for typing different subtypes of non-small cell lung cancer

[0045] 1. Design and synthesis of random nucleic acid library

[0046] Design and synthesize a random nucleic acid sequence library comprising 20 nucleotides at both ends and 45 nucleotides in the middle as follows: 5'-ACGCTCGGATGCCACTACAG(N 45 ) CTCATGGACGTGCTGGTGAC-3'.

[0047] 2. Screening of nucleic acid aptamers

[0048] Dissolve the random nucleic acid library in binding buffer (PBS, 150mM NaCl, 5mM MgCl 2 , 1mg / ml yeast transfer RNA), incubated with lung adenocarcinoma cell line A549 cells on ice for 1 hour; washed with buffer solution (PBS, 150mM NaCl, 5mM MgCl 2 ) after washing, the A549 cells were scraped off, and then the DNA bound to the cell surface was dissociated by heating; the dissociated DNA was incubated with the large cell lung cancer cell line HLAMP cells on ice for 1 hour, and the supernatant was collected and used DNA was used as a templ...

Embodiment 2

[0061] Example 2. Applying nucleic acid aptamers to type different subtypes of small cell lung cancer

[0062] The four aptamers obtained in Example 1 were labeled with fluorescein isothiocyanate (FITC). The random nucleic acid library of Example 1 was labeled with fluorescein isothiocyanate (FITC).

[0063] Different cultured tumor cells were washed twice with PBS, then treated with 0.02% EDTA for 3 minutes, and washed twice with PBS.

[0064] Each tumor cell was subjected to the following four groups of treatments, and each treatment was repeated three times, and the results were averaged:

[0065] Treatment 1: by cell counting, about 300,000 cells were respectively dispersed in the binding buffer solution, and then fluorescein isothiocyanate (FITC) was added to label the nucleic acid aptamer 1 (the final concentration was 100 nM).

[0066] Treatment 2: by cell counting, about 300,000 cells were collected and dispersed in the binding buffer solution, and then fluorescein i...

Embodiment 3

[0076] Example 3. Detection of the binding of the nucleic acid aptamers listed in Table 1 to lung cancer tissue sections

[0077] Formaldehyde-fixed paraffin-embedded tissue sections from different volunteers with lung cancer were dewaxed twice in xylene at room temperature for 20 minutes each time, and then immersed in a series of ethanol for hydration (100%, twice, 1 minute each time) ; 95% ethanol, 1 time, 1 minute; 70% ethanol, 1 time, 1 minute). The hydrated tissue sections were then immersed in buffer solution and heated at 95°C for 15 minutes. After the tissue sections returned to room temperature, they were incubated with binding buffer containing 20% ​​fetal bovine serum and calf thymus DNA for 1 hour at room temperature. After washing, the tissue sections were respectively combined with tetramethylrhodin-labeled nucleic acid aptamers (200nM) Incubate in buffer for 1 hour at room temperature. After staining, the tissue sections were washed 3 times with washing buffe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses aptamer for typing different subtypes of non-small cell lung cancer and a method for screening the same. The aptamer provided by the invention is any DNA segment of nucleotide expressed by sequence 1 to sequence 9 in a sequence table. The aptamer is applied for typing different subtypes of non-small cell lung cancer. The aptamer of the invention can differentiate the different subtypes of non-small cell lung cancer on the molecule response signal under the condition of not knowing tumor markers of the non-small cell lung cancer. Using the aptamer of the invention for identifying the combined target is good for discovering the tumor markers of the different subtypes of non-small cell lung cancer, and earlier and exactly diagnosing and typing non-small cell lung cancer and discovering the tumor for treating new drug action targets.

Description

technical field [0001] The invention relates to a nucleic acid aptamer for typing different subtypes of non-small cell lung cancer and a screening method thereof. Background technique [0002] Lung cancer is one of the deadliest cancers, histologically divided into small cell lung cancer and non-small cell lung cancer, with the latter accounting for 80% of lung cancer cases. Non-small cell lung cancer is divided into three subtypes: adenocarcinoma, squamous cell carcinoma and large cell carcinoma. Adenocarcinoma, the most dominant subtype, accounts for 40% of NSCLC. The prognosis of non-small cell lung cancer depends heavily on the stage of the disease at the time of diagnosis. According to the current treatment level, the 5-year survival rate of patients drops from 60% in stage I to 1% in stage IV. Although great progress has been made in the detection methods of lung cancer, about 70% of the patients are still in the advanced stage of lung cancer when they are diagnosed....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/11C12Q1/68C12N15/10C40B30/04C12P19/34C12N15/115
Inventor 方晓红赵子龙徐丽上官棣华谭蔚泓
Owner INST OF CHEM CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products